|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A REVIEW ARTICLE ON HYPERTENSION |
| Authors Name: | Sneha Rawat , Dr. Praveen Kumar Ashok , Reetu Papola |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_204703
|
| Published Paper Id: | IJNRD2309090 |
| Published In: | Volume 8 Issue 9, September-2023 |
| DOI: | |
| Abstract: | The most common modifiable risk factor for death and disability is hypertension, which includes stroke, accelerated coronary and systemic atherosclerosis, heart failure, chronic kidney disease, lowering blood pressure with antihypertensive drugs, and reducing target organ damage and the prevalence of the occurrence of cardiovascular disease. Reducing dietary sodium intake, losing weight if the patient is overweight, getting regular exercise, drinking moderately, and eating more potassium-rich foods were all recommended lifestyle changes. The first antihypertensive medication should be chosen from one of the four types known to minimise cardiovascular events: thiazide diuretics, ACE inhibitors, ARBs, and calcium channel blockers. In clinical practise, two interventional approaches—renal denervation and baroreflex activation therapy—are employed to treat a variety of treatment-resistant hypertensions. |
| Keywords: | Target Blood Pressure; Antihypertensive Drugs Therapy; Renal Denervation; Systemic arterial hypertension ; Renin-angiotensin-aldosterone system |
| Cite Article: | "A REVIEW ARTICLE ON HYPERTENSION ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 9, page no.a766-a776, September-2023, Available :http://www.ijnrd.org/papers/IJNRD2309090.pdf |
| Downloads: | 000118749 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2309090 Registration ID: 204703 Published In: Volume 8 Issue 9, September-2023 DOI (Digital Object Identifier): Page No: a766-a776 Country: Moradabad , Uttar Pradesh , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2309090 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2309090 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn